Approach to Diagnosis &
Management of Haemophilia
Step 1: Clinical suspicion
Case 1
Baby boy
DOB: 30th
July 2010
SVD, discharged well
That night, noted
bruise behind ears and
scalp swelling
Brought to A&E
Case 1 – clinical suspicion
Non-accidental injury (NAI)
Police report made
Case 1 – cont’d
Hb 4.5 g/dL
APTT x 3 >100 sec
Rx: PRBCs + FFP transfused
Case 1 – factor assay
Sample sent over to haemostasis lab
Within 1 hour
FVIII <1 %
vWF 90%
Δ: Severe haemophilia A
Do not mistake haemophilia for non-
accidental injury (NAI)
Bleeding – 2 types
1. Immediate bleeding
Defects in primary haemostasis
Vascular abnormality
2. Delayed bleeding
Defects in secondary haemostasis
Case 1 – Day 2 of life following SVD
Bleeding in haemophilia is delayed
Prompt
Accurate
Step 2: Laboratory confirmation
Case 2
2 year old boy
c/o sudden onset of
headache
Vomiting >10x
GCS: 12/15
Suspected posterior
fossa tumour
Courtesy of Dr Peter, March 2012
Case 2 – cont’d
Planned for emergency surgery
APTT 127 (36.9- 45.5) sec
Unable to do factor assay
Sample sent over to reference laboratory
Child deteriorated and died
Results came back 10 days later
FVIII < 1%
Case 3
5 year-old boy
Admitted for upper GI haemorrhage
h/o recurrent epistaxis and easy bruising
No f/h of bleeding
Hb 4.5 g/dL TW 4.5 Plt 398
Case 3 – cont’d
PT 12.o (11.5- 14.4) sec
APTT 102.0 (36.9- 45.5) sec
4 PRBC & 4 FFP transfused
Factor VIII 2.5%
Diagnosis: Moderate Haemophilia A
Case 3 – cont’d
Bleeding stopped with FFP x 3 doses
OGDS: pangastritis
Switched to hemofil M (high purity FVIII)
3 days later, re-bled
Hb fell from 11.o to 5.0 g/dL
APTT 98 sec Mixing studies 48 sec
Case 3 – cont’d
Suspected inhibitor; switched to PCC
Unable to do inhibitor assay
Sample sent to reference laboratory
FVIII 3% No inhibitor detected
vWF Ag < 1%
Diagnosis: severe type 3 vWD
Learn about haemophilia
Genetic risk & Carrier status
Inhibitor risk
Step 3: Counseling
Case 1 – Family history
Mom:
2 daughters
(10 and 6 years old)
6 younger siblings
No f/h of haemophilia
Case 1 – Family tree
?
NM
I
II
III
6 yrs
Case 1 – Counseling
D: Your son has been diagnosed with severe
haemophilia A. Have you heard about haemophilia?
M: No doctor, but from what I see it must be a serious
bleeding disorder
D: Explain about haemophilia
Haemophilia
Hereditary bleeding disorder
X-linked
Lack a clotting factor
factor VIII (HA) or factor IX (HB)
Blood fails to clot
Bleeds spontaneously in severe disease
20% present at birth
XH X
Carrier Woman Healthy Man
Carrier Girl Healthy Girl Haemophilic Boy Healthy Boy
XH
X
X X X XH Y X Y
Y
Inheritance
50% 50%
Classification of Haemophilia
Severity Factor level % Bleeding
Severe < 1 Spontaneous
Moderate 2 – 5 After minor trauma
Mild 6 – 40 After major trauma
or surgery
Management
Replace the factor that is missing
Vaccinations are not contraindicated but must be
given S/C
Learn about haemophilia and inhibitor risk
Learn to recognise bleeds
Need to report trauma or bleeding
Bruises or haematomas?
Avoid aspirin/ NSAIDs
Superficial cuts – OK
Platelets – primary haemostasis
IM injections must be avoided
Haemarrthrosis
right elbow
Haemarrthrosis – the hallmark of
haemophilia
Bleeding in haemophilia
1. Haemarrthrosis
Begin approx age 1 year
Spontaneous
May be preceded by ‘tingling’
Blood fills joint cavity
Rise in pressure is excruciatingly painful
Pressure eventually stops the bleeding
Blood damages cartilage
Joint becomes prone to recurrent bleeds
Target joint
Joint damage
Bleeding in haemophilia
2. Muscle bleeds
Often, apparently spontaneous
May result from exertion
Blood fills muscle capsule or compartment
Compartment syndrome may result
Pressure eventually stops the bleeding
Psoas bleed is a typical example
Psoas bleed
Muscle contractures
Case 1 – Counseling cont’d
M: Does that mean I am a carrier?
D: Possible but in 30% it may be a spontaneous
mutation
M: How do I know if I am a carrier?
Ratio <0.7
FVIII 82%
vWF antigen 81%
Ratio: 1.0
Genetic testing
Index patient (NM)
Intron 22 inversion by PCR
If negative
Intron 1 inversion
If both negative
DNA sequencing
Once mutation detected, screen mom
Case 1 – Result
NM- T1468X mutation
Mom- normal
So mom is not a carrier
Not at risk of having another child with haemophilia
No need to screen daughters and sisters
Rx of acute bleeds
Prevention of bleeds – Prophylaxis
Physiotherapy
Step 4: Treatment
Case 1 – Intracranial Haemorrhage
Factor replacement
D1 – D2: 100%
D3 – D4: 80%
D5 – D9: 50%
D11 – D14: 30%
Monitor FVIII levels
D1 – post dose, 6 – 8 h later
D2, D4, D6 – trough
time (hours)
Factorlevel(%)
0
25
75
100
50
0 362412
24
48
96
60VIII
IX
Factor replacement
Factor dosing
Formula:
Dose in units =
weight in kg x % rise in factor required
K factor
(K factor for FVIII = 2.0 , FIX = 1.0)
Physiotherapy
Start exercise once
pain subsides
Early restoration of
Full range of motion
Strength
Proprioception,
balance and
coordination
Case 1 – Prevention of bleeds
Started prophylaxis age 10
months at 50 IU/kg once a
week
After 4 months, difficulty
with venous access
Port-a-cath inserted on
11/10/11; age 14 months
Prophylaxis is the Rx of choice
Many studies
Prophylaxis prevents joint damage
Better joint scores
* Manco-Johnson
Prophylaxis (32 boys) vs. enhanced episodic therapy
(33 boys)
93% vs. 55% (normal MRI joints at 6 years)
Manco-Johnson MJ, NEJM 2007
Case 1 – Prophylaxis
Factor VIII replacement for
port-a-cath insertion
100% bolus
50% 8hrly D1- D2
50% 12hrly D3- D5
Followed by prophylaxis 25
iu/kg 3x/wk
Medic alert
Prophylaxis dose
Low dose (Utrecht)
15 – 30 IU/kg
High dose (Malmo)
25 – 40 IU/kg
3x/ week for HA
2x/ week for HB
 Principle:

to convert a severe haemophilia to
a moderate haemophilia
Petrini P, Haemophilia 2004
A Srivastava, Haemophilia 2012
Starting prophylaxis
Primary prophylaxis before any joint bleeds
Age 1 – 2 years
Primary prophylaxis after 1 or 2 joint bleeds
Damage already done
Explain about inhibitor risk
D: There is a 15 – 30% risk of
inhibitor development
P: What is an inhibitor?
D: An inhibitor is an antibody
against the infused factor VIII
P: Why is it important?
D: It will render treatment with
FVIII useless
Prophylaxis protects against inhibitor
development
Gouw SC et al. Blood 2007;109(6)4648-4654
Self-infusion & Dosing
Recognising problems
Communicating
Step 5: Caregiver & Patient education
Mom taught to infuse
Starting home therapy
Home therapy
Self-infusion
Home & School Visits
Communicate
If any doubts
If bleeding not
resolved
In an emergency
If factors running low
Plan your travels
Dental check-ups
½ - 1 yearly
Prevention is better
Physiotherapy
Know your exercises
Keep to your
appointments
Approach to Diagnosis & Mx of
Haemophilia: 5 steps
Step 1: Clinical suspicion
Step 2: Laboratory confirmation – prompt &
accurate
Step 3: Counseling & carrier detection
Step 4: Treatment/ Home therapy
Step 5: Parent/ Caregiver/ Patient education
Thank you
The end

More Related Content

PPSX
Ppt fl & el
PDF
Malnutrition, microcephaly &amp; macrocephly, respiratory system (pneumonia),...
PPTX
Differential Diagnosis of Arthritis in Children
PDF
Pediatric rheumatology 2021
PPTX
Approach to anemia in children
PPTX
Burns in pediatrics
PPTX
CONGENITAL INFECTION (Cytomegalovirus & Toxoplasmosis)
PPTX
Congenital Cystic Adenomatoid Malformation
Ppt fl & el
Malnutrition, microcephaly &amp; macrocephly, respiratory system (pneumonia),...
Differential Diagnosis of Arthritis in Children
Pediatric rheumatology 2021
Approach to anemia in children
Burns in pediatrics
CONGENITAL INFECTION (Cytomegalovirus & Toxoplasmosis)
Congenital Cystic Adenomatoid Malformation

What's hot (20)

PPSX
Neonatal sepsis...ppt
PPT
Stroke in pediatrics
PDF
Epilepsy mimics in childern
PDF
Heart failure in children 2021
PPTX
Pediatric stroke
PPTX
PPTX
Approach to seizures in a child
PPT
Hypoxic ischemic encephalopathy: Lecture on HIE
PDF
Floppy infant
PPTX
Bronchiolitis | Case Study
PPTX
Abnormal body movement in children
PPTX
Hypoxic ischemic encephalopathy
PPTX
Snake bite management in Pediatrics.. Dr.Padmesh. V
PDF
Cyanotic congenital heart disease 2021
PPTX
Neurocutaneous syndromes
PPTX
Pediatric cardiomyopathy
PPTX
Febrile neutropenia in chidren
PPT
Snake bite in pediatrics
PPTX
Lung malformation part 1
Neonatal sepsis...ppt
Stroke in pediatrics
Epilepsy mimics in childern
Heart failure in children 2021
Pediatric stroke
Approach to seizures in a child
Hypoxic ischemic encephalopathy: Lecture on HIE
Floppy infant
Bronchiolitis | Case Study
Abnormal body movement in children
Hypoxic ischemic encephalopathy
Snake bite management in Pediatrics.. Dr.Padmesh. V
Cyanotic congenital heart disease 2021
Neurocutaneous syndromes
Pediatric cardiomyopathy
Febrile neutropenia in chidren
Snake bite in pediatrics
Lung malformation part 1

Viewers also liked (20)

PPTX
Hemophilia by Suhasis Mondal
PPT
Hemophilia
PPT
Coagulation disorder
PPTX
Approach to bleeding disorder (coagulation defects) in children
PPTX
Bleeding & clotting disorders
PPTX
Bio chem presentation on hemophilia
PPT
Respiratory distress syndrome
PPTX
Thalassaemia foong
PPT
Diabetes type 1
PPT
Hemophilia
PPT
Nephrotic syndrome
PPTX
Meconium aspiration syndrome
PPT
Infant and paediatric nutrition update 2014
PPT
Congenital Heart Disease
PPTX
Diagnostic approach to acute encephalopathy
PPT
SVT in pediatrics
PPT
CME: Bleeding disorders - Diagnostic Approach
PPTX
HIV in pediatric
PPT
Peadiatric eye assessment
PPT
Pediatric Parenteral Nutrition
Hemophilia by Suhasis Mondal
Hemophilia
Coagulation disorder
Approach to bleeding disorder (coagulation defects) in children
Bleeding & clotting disorders
Bio chem presentation on hemophilia
Respiratory distress syndrome
Thalassaemia foong
Diabetes type 1
Hemophilia
Nephrotic syndrome
Meconium aspiration syndrome
Infant and paediatric nutrition update 2014
Congenital Heart Disease
Diagnostic approach to acute encephalopathy
SVT in pediatrics
CME: Bleeding disorders - Diagnostic Approach
HIV in pediatric
Peadiatric eye assessment
Pediatric Parenteral Nutrition

Similar to Hemophilia talk (20)

PPT
Wiskott Aldrich Syndrome Final Powerpoint
PDF
2nd Pediatric On Squares Pediatric Board Review.pdf
PDF
Palpitations In The Young Patients: Another False Alarm?
PPTX
Mod 1 case 2022
PPTX
Simon holden red flags rare disease crdn summit 2017
PPTX
Pediatric radiology
PPTX
33 - Renal Transplantmmmmmmmmmmmmmmmation.pptx
PPTX
Oncology at the periphery by matilda ong'ondi
PPTX
Oncology at the periphery by matilda ong'ondi
PPTX
Cerebral Venous Sinus Thrombosis 2010 - Dr. Rajiv Jha (Neurosurgeon Nepal)
PPTX
Deep Venous Thrombosis power point presentation
PPTX
HYDROPS
PPTX
Treatment of VTE in hospital patients today
PPT
Acute pulmonary thromboembolism
PPT
Francesco Procaccio - Italy - Tuesday 29 - Donor Risk
DOCX
1. A community health nurse practitioner is teaching a group of fema.docx
PPT
Ta gvhd
PDF
Venous Thromboembolism and Pregnancy
DOCX
Germany info Geography homework help.docx
PPSX
TC's Emergency Medicine Wrap Up 5
Wiskott Aldrich Syndrome Final Powerpoint
2nd Pediatric On Squares Pediatric Board Review.pdf
Palpitations In The Young Patients: Another False Alarm?
Mod 1 case 2022
Simon holden red flags rare disease crdn summit 2017
Pediatric radiology
33 - Renal Transplantmmmmmmmmmmmmmmmation.pptx
Oncology at the periphery by matilda ong'ondi
Oncology at the periphery by matilda ong'ondi
Cerebral Venous Sinus Thrombosis 2010 - Dr. Rajiv Jha (Neurosurgeon Nepal)
Deep Venous Thrombosis power point presentation
HYDROPS
Treatment of VTE in hospital patients today
Acute pulmonary thromboembolism
Francesco Procaccio - Italy - Tuesday 29 - Donor Risk
1. A community health nurse practitioner is teaching a group of fema.docx
Ta gvhd
Venous Thromboembolism and Pregnancy
Germany info Geography homework help.docx
TC's Emergency Medicine Wrap Up 5

Recently uploaded (20)

PPTX
ENT-DISORDERS ( ent for nursing ). (1).p
PPTX
Bronchial Asthma2025 GINA Guideline.pptx
PPT
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
PDF
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
PPTX
Approch to weakness &paralysis pateint.pptx
PDF
periodontaldiseasesandtreatments-200626195738.pdf
PPTX
Communicating with the FDA During an Inspection -August 26, 2025 - GMP.pptx
PPTX
LIVER DIORDERS OF PREGNANCY in detail PPT.pptx
PDF
The Role of Medicinal Plants in Alleviating Symptoms of Diabetes-Related Com...
PPTX
Local Anesthesia Local Anesthesia Local Anesthesia
PPTX
Bacteriology and purification of water supply
PPTX
Computed Tomography: Hardware and Instrumentation
PPTX
GAIT IN HUMAN AMD PATHOLOGICAL GAIT ...............
PDF
FMCG-October-2021........................
PPTX
A Detailed Physiology of Endocrine System.pptx
PDF
Integrating Traditional Medicine with Modern Engineering Solutions (www.kiu....
PDF
NCCN CANCER TESTICULAR 2024 ...............................
PPTX
Phamacology Presentation (Anti cance drugs).pptx
PPTX
This book is about some common childhood
PDF
Cranial nerve palsies (I-XII) - AMBOSS.pdf
ENT-DISORDERS ( ent for nursing ). (1).p
Bronchial Asthma2025 GINA Guideline.pptx
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
Approch to weakness &paralysis pateint.pptx
periodontaldiseasesandtreatments-200626195738.pdf
Communicating with the FDA During an Inspection -August 26, 2025 - GMP.pptx
LIVER DIORDERS OF PREGNANCY in detail PPT.pptx
The Role of Medicinal Plants in Alleviating Symptoms of Diabetes-Related Com...
Local Anesthesia Local Anesthesia Local Anesthesia
Bacteriology and purification of water supply
Computed Tomography: Hardware and Instrumentation
GAIT IN HUMAN AMD PATHOLOGICAL GAIT ...............
FMCG-October-2021........................
A Detailed Physiology of Endocrine System.pptx
Integrating Traditional Medicine with Modern Engineering Solutions (www.kiu....
NCCN CANCER TESTICULAR 2024 ...............................
Phamacology Presentation (Anti cance drugs).pptx
This book is about some common childhood
Cranial nerve palsies (I-XII) - AMBOSS.pdf

Hemophilia talk

  • 1. Approach to Diagnosis & Management of Haemophilia
  • 2. Step 1: Clinical suspicion
  • 3. Case 1 Baby boy DOB: 30th July 2010 SVD, discharged well That night, noted bruise behind ears and scalp swelling Brought to A&E
  • 4. Case 1 – clinical suspicion Non-accidental injury (NAI) Police report made
  • 5. Case 1 – cont’d Hb 4.5 g/dL APTT x 3 >100 sec Rx: PRBCs + FFP transfused
  • 6. Case 1 – factor assay Sample sent over to haemostasis lab Within 1 hour FVIII <1 % vWF 90% Δ: Severe haemophilia A
  • 7. Do not mistake haemophilia for non- accidental injury (NAI)
  • 8. Bleeding – 2 types 1. Immediate bleeding Defects in primary haemostasis Vascular abnormality 2. Delayed bleeding Defects in secondary haemostasis
  • 9. Case 1 – Day 2 of life following SVD Bleeding in haemophilia is delayed
  • 11. Case 2 2 year old boy c/o sudden onset of headache Vomiting >10x GCS: 12/15 Suspected posterior fossa tumour Courtesy of Dr Peter, March 2012
  • 12. Case 2 – cont’d Planned for emergency surgery APTT 127 (36.9- 45.5) sec Unable to do factor assay Sample sent over to reference laboratory Child deteriorated and died Results came back 10 days later FVIII < 1%
  • 13. Case 3 5 year-old boy Admitted for upper GI haemorrhage h/o recurrent epistaxis and easy bruising No f/h of bleeding Hb 4.5 g/dL TW 4.5 Plt 398
  • 14. Case 3 – cont’d PT 12.o (11.5- 14.4) sec APTT 102.0 (36.9- 45.5) sec 4 PRBC & 4 FFP transfused Factor VIII 2.5% Diagnosis: Moderate Haemophilia A
  • 15. Case 3 – cont’d Bleeding stopped with FFP x 3 doses OGDS: pangastritis Switched to hemofil M (high purity FVIII) 3 days later, re-bled Hb fell from 11.o to 5.0 g/dL APTT 98 sec Mixing studies 48 sec
  • 16. Case 3 – cont’d Suspected inhibitor; switched to PCC Unable to do inhibitor assay Sample sent to reference laboratory FVIII 3% No inhibitor detected vWF Ag < 1% Diagnosis: severe type 3 vWD
  • 17. Learn about haemophilia Genetic risk & Carrier status Inhibitor risk Step 3: Counseling
  • 18. Case 1 – Family history Mom: 2 daughters (10 and 6 years old) 6 younger siblings No f/h of haemophilia
  • 19. Case 1 – Family tree ? NM I II III 6 yrs
  • 20. Case 1 – Counseling D: Your son has been diagnosed with severe haemophilia A. Have you heard about haemophilia? M: No doctor, but from what I see it must be a serious bleeding disorder D: Explain about haemophilia
  • 21. Haemophilia Hereditary bleeding disorder X-linked Lack a clotting factor factor VIII (HA) or factor IX (HB) Blood fails to clot Bleeds spontaneously in severe disease 20% present at birth
  • 22. XH X Carrier Woman Healthy Man Carrier Girl Healthy Girl Haemophilic Boy Healthy Boy XH X X X X XH Y X Y Y Inheritance 50% 50%
  • 23. Classification of Haemophilia Severity Factor level % Bleeding Severe < 1 Spontaneous Moderate 2 – 5 After minor trauma Mild 6 – 40 After major trauma or surgery
  • 24. Management Replace the factor that is missing Vaccinations are not contraindicated but must be given S/C Learn about haemophilia and inhibitor risk Learn to recognise bleeds Need to report trauma or bleeding
  • 26. Avoid aspirin/ NSAIDs Superficial cuts – OK Platelets – primary haemostasis
  • 27. IM injections must be avoided
  • 28. Haemarrthrosis right elbow Haemarrthrosis – the hallmark of haemophilia
  • 29. Bleeding in haemophilia 1. Haemarrthrosis Begin approx age 1 year Spontaneous May be preceded by ‘tingling’ Blood fills joint cavity Rise in pressure is excruciatingly painful Pressure eventually stops the bleeding Blood damages cartilage Joint becomes prone to recurrent bleeds
  • 32. Bleeding in haemophilia 2. Muscle bleeds Often, apparently spontaneous May result from exertion Blood fills muscle capsule or compartment Compartment syndrome may result Pressure eventually stops the bleeding Psoas bleed is a typical example
  • 35. Case 1 – Counseling cont’d M: Does that mean I am a carrier? D: Possible but in 30% it may be a spontaneous mutation M: How do I know if I am a carrier?
  • 36. Ratio <0.7 FVIII 82% vWF antigen 81% Ratio: 1.0
  • 37. Genetic testing Index patient (NM) Intron 22 inversion by PCR If negative Intron 1 inversion If both negative DNA sequencing Once mutation detected, screen mom
  • 38. Case 1 – Result NM- T1468X mutation Mom- normal So mom is not a carrier Not at risk of having another child with haemophilia No need to screen daughters and sisters
  • 39. Rx of acute bleeds Prevention of bleeds – Prophylaxis Physiotherapy Step 4: Treatment
  • 40. Case 1 – Intracranial Haemorrhage Factor replacement D1 – D2: 100% D3 – D4: 80% D5 – D9: 50% D11 – D14: 30% Monitor FVIII levels D1 – post dose, 6 – 8 h later D2, D4, D6 – trough
  • 42. Factor dosing Formula: Dose in units = weight in kg x % rise in factor required K factor (K factor for FVIII = 2.0 , FIX = 1.0)
  • 43. Physiotherapy Start exercise once pain subsides Early restoration of Full range of motion Strength Proprioception, balance and coordination
  • 44. Case 1 – Prevention of bleeds Started prophylaxis age 10 months at 50 IU/kg once a week After 4 months, difficulty with venous access Port-a-cath inserted on 11/10/11; age 14 months
  • 45. Prophylaxis is the Rx of choice Many studies Prophylaxis prevents joint damage Better joint scores * Manco-Johnson Prophylaxis (32 boys) vs. enhanced episodic therapy (33 boys) 93% vs. 55% (normal MRI joints at 6 years) Manco-Johnson MJ, NEJM 2007
  • 46. Case 1 – Prophylaxis Factor VIII replacement for port-a-cath insertion 100% bolus 50% 8hrly D1- D2 50% 12hrly D3- D5 Followed by prophylaxis 25 iu/kg 3x/wk Medic alert
  • 47. Prophylaxis dose Low dose (Utrecht) 15 – 30 IU/kg High dose (Malmo) 25 – 40 IU/kg 3x/ week for HA 2x/ week for HB  Principle:  to convert a severe haemophilia to a moderate haemophilia Petrini P, Haemophilia 2004 A Srivastava, Haemophilia 2012
  • 48. Starting prophylaxis Primary prophylaxis before any joint bleeds Age 1 – 2 years Primary prophylaxis after 1 or 2 joint bleeds Damage already done
  • 49. Explain about inhibitor risk D: There is a 15 – 30% risk of inhibitor development P: What is an inhibitor? D: An inhibitor is an antibody against the infused factor VIII P: Why is it important? D: It will render treatment with FVIII useless
  • 50. Prophylaxis protects against inhibitor development Gouw SC et al. Blood 2007;109(6)4648-4654
  • 51. Self-infusion & Dosing Recognising problems Communicating Step 5: Caregiver & Patient education
  • 52. Mom taught to infuse
  • 56. Home & School Visits
  • 57. Communicate If any doubts If bleeding not resolved In an emergency If factors running low Plan your travels
  • 58. Dental check-ups ½ - 1 yearly Prevention is better
  • 60. Approach to Diagnosis & Mx of Haemophilia: 5 steps Step 1: Clinical suspicion Step 2: Laboratory confirmation – prompt & accurate Step 3: Counseling & carrier detection Step 4: Treatment/ Home therapy Step 5: Parent/ Caregiver/ Patient education

Editor's Notes

  • #12: Posterior fossa tumour
  • #15: This hospital can only do FVIII and FIX levels
  • #17: Diagnosis: severe type 3 vWD vWF &amp;lt;1%
  • #23: Carrier mother has a 50% chance of having a daughter who will be a carrier and a 50% chance of having a son who is a haemophilia ie. 25% chance of passing on the gene with each pregnancy.
  • #28: No aspirin or NSAIDs
  • #46: 2 RCTs- the other Italian study Gringeri: 21 prophy; 19 OD; Jt damage 29% prophy; 74% OD at 6 years